Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / *W EXP 08/10/202
-
Total 13F shares
-
974,267
-
Share change
-
+782,511
-
Total reported value
-
$1,084,417
-
Price per share
-
$1.10
-
Number of holders
-
8
-
Value change
-
+$862,956
-
Number of buys
-
2
-
Number of sells
-
5
Institutional Holders of TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) as of Q4 2024
As of 31 Dec 2024,
TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
974,267 shares.
The largest 8 holders included
Graypoint LLC, Vestcor Inc, B & T Capital Management DBA Alpha Capital Management, HRT FINANCIAL LP, Foster Victor Wealth Advisors, LLC, WOLVERINE ASSET MANAGEMENT LLC, CLEAR STREET LLC, and Tower Research Capital LLC (TRC).
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.